Evidence map›Paper›PMID 32693671›Full record

ArticleBioengineered2020

Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines.

Somi Jeong, Seunghwa Jung, Gyun-Seok Park, Juhyun Shin, Jae-Wook Oh

Abstract read
In one paragraph

Article in Bioengineered, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. The Hidden Power of Black Pepper: Exploring Piperine's Role in Cancer.Plant foods for human nutrition (Dordrecht, Netherlands) · 2025
    Review
  3. Review
  4. Gintonin-EnrichedFoods (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Evaluating the Diverse Anticancer Effects of LaosMedicina (Kaunas, Lithuania) · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Somi JeongDepartment of Stem Cell and Regenerative Biotechnology, Konkuk Institute of Technology, Konkuk University , Seoul, Korea.
Seunghwa JungDepartment of Stem Cell and Regenerative Biotechnology, Konkuk Institute of Technology, Konkuk University , Seoul, Korea.
Gyun-Seok ParkDepartment of Bio-resources and Food Science, Konkuk University , Seoul, Korea.
Juhyun ShinDepartment of Stem Cell and Regenerative Biotechnology, Konkuk Institute of Technology, Konkuk University , Seoul, Korea.
Jae-Wook OhDepartment of Stem Cell and Regenerative Biotechnology, Konkuk Institute of Technology, Konkuk University , Seoul, Korea.ORCID 0000-0003-2439-0499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Temozolomide (TMZ) is an alkylating chemotherapy agent used in the clinical treatment of glioblastoma multiforme (GBM) patients. Piperine (PIP) is a naturally occurring pungent nitrogenous substance present in the fruits of peppers. We investigated the anti-cancer efficacies of PIP alone and in combination with TMZ in GBM cellsusingparameters such as cell proliferation, cellular apoptosis,caspase-8/-9/-3 activities, cell cycle kinetics, wound-healing ability, and loss of mitochondrial membrane potential (MMP). Treatment with PIP and alow concentration of PIP-TMZ, inhibited cell growth, similar to TMZ.PIP-TMZ promoted apoptosis by activation of caspase-8/-9/-3, MMP loss, and inhibition of

Indexed as

AlkaloidsApoptosisBenzodioxolesCell CycleCell Line, TumorCell ProliferationDrug SynergismGliomaHumansMembrane Potential, MitochondrialPiperidinesPolyunsaturated AlkamidesTemozolomideAlkaloidsBenzodioxolesPiperidinespiperinePolyunsaturated AlkamidesTemozolomideapoptosisglioblastoma multiformeinhibition of cell growthPiperinetemozolomide

Identifiers

PMID32693671
PMCPMC8291786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.